Detalhe da pesquisa
1.
First-line atezolizumab monotherapy versus single-agent chemotherapy in patients with non-small-cell lung cancer ineligible for treatment with a platinum-containing regimen (IPSOS): a phase 3, global, multicentre, open-label, randomised controlled study.
Lancet
; 402(10400): 451-463, 2023 08 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37423228
2.
Novel Therapeutic Options for Small Cell Lung Cancer.
Curr Oncol Rep
; 25(11): 1277-1294, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37870696
3.
A cross-sectional analysis of treatment patterns in small-cell lung cancer in five European countries.
Future Oncol
; 2023 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38031886
4.
An Overview of PARP Resistance in Ovarian Cancer from a Molecular and Clinical Perspective.
Int J Mol Sci
; 24(15)2023 Jul 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37569269
5.
The "digital biopsy" in non-small cell lung cancer (NSCLC): a pilot study to predict the PD-L1 status from radiomics features of [18F]FDG PET/CT.
Eur J Nucl Med Mol Imaging
; 49(10): 3401-3411, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35403860
6.
Evaluating the impact of chemotherapy-induced nausea and vomiting on daily functioning in patients receiving dexamethasone-sparing antiemetic regimens with NEPA (netupitant/palonosetron) in the cisplatin setting: results from a randomized phase 3 study.
BMC Cancer
; 22(1): 915, 2022 Aug 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35999527
7.
Clinical treatment of cholangiocarcinoma: an updated comprehensive review.
Ann Hepatol
; 27(5): 100737, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35809836
8.
Dexamethasone-Sparing Regimens with Oral Netupitant and Palonosetron for the Prevention of Emesis Caused by High-Dose Cisplatin: A Randomized Noninferiority Study.
Oncologist
; 26(10): e1854-e1861, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34101934
9.
Validation of the Italian version of the full and abbreviated Trust in Oncologist Scale.
Eur J Cancer Care (Engl)
; 30(1): e13334, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33015898
10.
Immunotherapy in Underrepresented Populations of Patients with Cancer: Do We Have Enough Evidence at Present? A Focus on Patients with Major Viral Infections and Autoimmune Disorders.
Oncologist
; 25(6): e946-e954, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32181960
11.
Clinicopathologic correlates of first-line pembrolizumab effectiveness in patients with advanced NSCLC and a PD-L1 expression of ≥ 50.
Cancer Immunol Immunother
; 69(11): 2209-2221, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32474768
12.
Targeted Therapies in Early Stage NSCLC: Hype or Hope?
Int J Mol Sci
; 21(17)2020 Aug 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-32878298
13.
Peritoneal carcinomatosis in non-small-cell lung cancer: retrospective multicentric analysis and literature review.
Future Oncol
; 15(9): 989-994, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30681378
14.
Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial.
Lancet
; 389(10066): 255-265, 2017 01 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-27979383
15.
First-line ceritinib versus platinum-based chemotherapy in advanced ALK-rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study.
Lancet
; 389(10072): 917-929, 2017 03 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28126333
16.
Blood cell count indexes as predictors of outcomes in advanced non-small-cell lung cancer patients treated with Nivolumab.
Cancer Immunol Immunother
; 67(9): 1349-1353, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-29947960
17.
Challenges in ALK inhibition of ALK-positive non-small-cell lung cancer: from ALK positivity detection to treatment strategies after relapse.
Future Oncol
; 14(22): 2303-2317, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-30088419
18.
Risk stratification of oxaliplatin induced peripheral neurotoxicity applying electrophysiological testing of dorsal sural nerve.
Support Care Cancer
; 26(9): 3143-3151, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-29594485
19.
A primarily clinician's responsibility.
Pediatr Blood Cancer
; 69(9): e29612, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35195338
20.
Genetic determinants of chronic oxaliplatin-induced peripheral neurotoxicity: a genome-wide study replication and meta-analysis.
J Peripher Nerv Syst
; 20(1): 15-23, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25858589